Therapeutic Targeting of the Leukaemia Microenvironment

In recent decades, the conduct of uniform prospective clinical trials has led to improved remission rates and survival for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia. However, high-risk patients continue to have inferior outcomes, where chemoresistance and relapse are co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuek, Vincent, Hughes, Anastasia M., Kotecha, Rishi S., Cheung, Laurence C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267786/
https://www.ncbi.nlm.nih.gov/pubmed/34206957
http://dx.doi.org/10.3390/ijms22136888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267786/
https://www.ncbi.nlm.nih.gov/pubmed/34206957
http://dx.doi.org/10.3390/ijms22136888

Ejemplares similares